FOR IMMEDIATE RELEASE | 3 October 2012 |
ImmuPharma plc
(the "Company")
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer | IMMUPHARMA PLC (ISIN = GB0033711010) | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | x | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | ||||
3. Full name of person(s) subject to the | ING Groep N.V. | |||
4. Full name of shareholder(s) | N/A | |||
5. Date of the transaction and date on | 01 October 2012 | |||
6. Date on which issuer notified: | 02 October 2012 | |||
7. Threshold(s) that is/are crossed or | 3% | |||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type of if possible using | Situation previous | Resulting situation after the triggering transaction | ||||||||||||||
Number | Number | Number | Number of voting | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
Ordinary Shares GB0033711010 | 2,462,669 | 2,462,669 | 2,445,669 | 2,445,669 | 0 | 2.9996% | 2.9996% | |||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial | Expiration | Exercise/ | Number of voting | % of voting | ||||||||||||
N/A | N/A | N/A | N/A | N/A | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial | Exercise price | Expiration date | Exercise/ | Number of voting rights instrument refers to | % of voting rights | |||||||||||
N/A | N/A | N/A | N/A | N/A | Nominal | Delta | ||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
2,445,669 | 2.9996% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the | ||
N/A | ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will cease | N/A | |
12. Date on which proxy holder will cease to hold | N/A | |
13. Additional information: | N/A | |
14. Contact name: | Tracy Weimar, Vice President, Operations and Company Secretary | |
15. Contact telephone number: | 020 7152 4080 | |

